Colgate-Palmolive Company (CL) PT Raised to $122 at UBS
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/1/2026
- Wall Street closes sharply lower as AI cash burn fears spark tech selloff
- Amazon burns cash, Intel flags weak PC demand as AI boom's costs ripple across markets
- Bitcoin, cryptocurrency prices fall after Binance reports security issue
- Higher yields now hurting AI stock bull as bond markets police capex: BofA
- Oil jumps 2%, settles at 6-month highs on fears of escalation in Iran
Tweet
Share
E-mailGet Alerts CL Hot Sheet
Price: $95.29 +2.29%
Rating Summary:
18 Buy, 15 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 14 | Down: 50 | New: 9
Rating Summary:
18 Buy, 15 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 14 | Down: 50 | New: 9
Join SI Premium – FREE
UBS analyst Peter Grom raised the price target on Colgate-Palmolive Company (NYSE: CL) to $122.00 (from $119.00) while maintaining a Buy rating.
You May Also Be Interested In
- Colgate-Palmolive Company (CL) PT Raised to $92 at Jefferies
- Alnylam Pharmaceuticals (ALNY) PT Lowered to $350 at Freedom Broker
- Colgate-Palmolive (CL) Tops Q3 EPS by 4c, Beats on Revenue; Offers Guidance
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
